MYLAN 7155 MYLAN 7155 (Budesonide (Enteric Coated) 3 mg)

Pill with imprint MYLAN 7155 MYLAN 7155 is Red, Capsule-shape and has been identified as Budesonide (Enteric Coated) 3 mg. It is supplied by Mylan Pharmaceuticals Inc..

Budesonide is used in the treatment of crohn's disease; asthma, maintenance; crohn's disease, acute; inflammatory bowel disease; crohn's disease, maintenance and belongs to the drug classes glucocorticoids, inhaled corticosteroids. Risk cannot be ruled out during pregnancy. Budesonide 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 7155 MYLAN 7155

Budesonide (Enteric Coated)

Imprint:

MYLAN 7155 MYLAN 7155

Strength:

3 mg

Color:

Red

Size:

18.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Glucocorticoids
Inhaled corticosteroids

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

• acetyltributyl citrate
• silicon dioxide
• dimethicone
• ethylcelluloses
• FD&C Red No. 40
• gelatin
• lactose monohydrate
• magnesium stearate
• methacrylic acid - ethyl acrylate copolymer (1:1) type a
• polysorbate 80
• sodium hydroxide
• sodium lauryl sulfate
• magnesium silicate
• titanium dioxide
• triethyl citrate
• ferrosoferric oxide
• D&C Yellow No. 10
• FD&C Blue No. 1
• FD&C Blue No. 2
• propylene glycol
• shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00378-7155	Mylan Pharmaceuticals Inc.
51079-0020	UDL Laboratories Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer